| A gene map of the human genome. Science 275 (5287), 540-546, 1996 | 1366* | 1996 |
| Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene H Ichinose, T Ohye, E Takahashi, N Seki, T Hori, M Segawa, Y Nomura, ... Nature genetics 8 (3), 236-242, 1994 | 967 | 1994 |
| Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease H Sumi, O Yokosuka, N Seki, M Arai, F Imazeki, T Kurihara, T Kanda, ... Hepatology 37 (1), 19-26, 2003 | 641 | 2003 |
| miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma M Kano, N Seki, N Kikkawa, L Fujimura, I Hoshino, Y Akutsu, T Chiyomaru, ... International journal of cancer 127 (12), 2804-2814, 2010 | 547 | 2010 |
| Identification of novel microRNA targets based on microRNA signatures in bladder cancer T Ichimi, H Enokida, Y Okuno, R Kunimoto, T Chiyomaru, K Kawamoto, ... International journal of cancer 125 (2), 345-352, 2009 | 495 | 2009 |
| Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones … N Nomura, N Miyajima, T Sazuka, A Tanaka, Y Kawarabayasi, S Sato, ... DNA research 1 (1), 27-35, 1994 | 434 | 1994 |
| miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer T Chiyomaru, H Enokida, S Tatarano, K Kawahara, Y Uchida, ... British journal of cancer 102 (5), 883-891, 2010 | 401 | 2010 |
| Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t (2; 5). J Fujimoto, M Shiota, T Iwahara, N Seki, H Satoh, S Mori, T Yamamoto Proceedings of the National Academy of Sciences 93 (9), 4181-4186, 1996 | 346 | 1996 |
| Molecular cloning and chromosomal localization of the human thrombopoietin gene Y Sohma, H Akahori, N Seki, T Hori, K Ogami, T Kato, Y Shimada, ... FEBS letters 353 (1), 57-61, 1994 | 319 | 1994 |
| The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer H Yoshino, T Chiyomaru, H Enokida, K Kawakami, S Tatarano, ... British journal of cancer 104 (5), 808-818, 2011 | 312 | 2011 |
| Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR T Chiyomaru, S Yamamura, S Fukuhara, H Yoshino, T Kinoshita, S Majid, ... PloS one 8 (8), e70372, 2013 | 285 | 2013 |
| microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers N Nohata, T Hanazawa, H Enokida, N Seki Oncotarget 3 (1), 9, 2012 | 277 | 2012 |
| MiR‐96 and miR‐183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology Y Yamada, H Enokida, S Kojima, K Kawakami, T Chiyomaru, S Tatarano, ... Cancer science 102 (3), 522-529, 2011 | 272 | 2011 |
| Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro T Nagase, K Ishikawa, D Nakajima, M Ohira, N Seki, N Miyajima, ... DNA Research 4 (2), 141-150, 1997 | 265 | 1997 |
| Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line … T Nagase, N Seki, K Ishikawa, M Ohira, Y Kawarabayasi, O Ohara, ... DNA Research 3 (5), 321-329, 1996 | 261 | 1996 |
| PKCν, a new member of the protein kinase C family, composes a fourth subfamily with PKCμ A Hayashi, N Seki, A Hattori, S Kozuma, T Saito Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1450 (1), 99-106, 1999 | 258 | 1999 |
| Aberrant expression of microRNAs in bladder cancer H Yoshino, N Seki, T Itesako, T Chiyomaru, M Nakagawa, H Enokida Nature Reviews Urology 10 (7), 396-404, 2013 | 243 | 2013 |
| Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer S Kojima, T Chiyomaru, K Kawakami, H Yoshino, H Enokida, N Nohata, ... British journal of cancer 106 (2), 405-413, 2012 | 232 | 2012 |
| Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening M Nakayama, D Nakajima, T Nagase, N Nomura, N Seki, O Ohara Genomics 51 (1), 27-34, 1998 | 215 | 1998 |
| Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma H Hidaka, N Seki, H Yoshino, T Yamasaki, Y Yamada, N Nohata, M Fuse, ... Oncotarget 3 (1), 44, 2012 | 214 | 2012 |
Nijiro Nohata, M.D., Ph.D.MSD K.K.Verified email at merck.com
